nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroxoline—METAP2—forebrain—epilepsy syndrome	0.133	0.154	CbGeAlD
Nitroxoline—METAP2—telencephalon—epilepsy syndrome	0.122	0.141	CbGeAlD
Nitroxoline—METAP2—medulla oblongata—epilepsy syndrome	0.0962	0.111	CbGeAlD
Nitroxoline—METAP2—midbrain—epilepsy syndrome	0.0879	0.101	CbGeAlD
Nitroxoline—METAP2—spinal cord—epilepsy syndrome	0.0858	0.099	CbGeAlD
Nitroxoline—METAP2—head—epilepsy syndrome	0.0763	0.0879	CbGeAlD
Nitroxoline—METAP2—nervous system—epilepsy syndrome	0.0723	0.0834	CbGeAlD
Nitroxoline—METAP2—central nervous system—epilepsy syndrome	0.0696	0.0803	CbGeAlD
Nitroxoline—METAP2—cerebellum—epilepsy syndrome	0.068	0.0785	CbGeAlD
Nitroxoline—METAP2—brain—epilepsy syndrome	0.0553	0.0637	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—APOE—epilepsy syndrome	0.00483	0.0364	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PDXK—epilepsy syndrome	0.00364	0.0274	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PNPO—epilepsy syndrome	0.00333	0.025	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EPM2A—epilepsy syndrome	0.00333	0.025	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NHLRC1—epilepsy syndrome	0.00333	0.025	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SV2A—epilepsy syndrome	0.00309	0.0233	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PFKL—epilepsy syndrome	0.00276	0.0207	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STX1B—epilepsy syndrome	0.00252	0.019	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CPSF4—epilepsy syndrome	0.00234	0.0176	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PPP1R3C—epilepsy syndrome	0.00234	0.0176	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GBE1—epilepsy syndrome	0.00234	0.0176	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRDM4—epilepsy syndrome	0.00233	0.0175	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.00233	0.0175	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ACKR4—epilepsy syndrome	0.00204	0.0153	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ST3GAL3—epilepsy syndrome	0.00195	0.0147	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SSTR4—epilepsy syndrome	0.00184	0.0139	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SSTR5—epilepsy syndrome	0.00184	0.0139	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCR10—epilepsy syndrome	0.00177	0.0133	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GRM2—epilepsy syndrome	0.00154	0.0116	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EIF2AK2—epilepsy syndrome	0.00142	0.0107	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SSTR3—epilepsy syndrome	0.0014	0.0105	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.00137	0.0103	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NPY2R—epilepsy syndrome	0.00134	0.0101	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SSTR1—epilepsy syndrome	0.00134	0.0101	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCR8—epilepsy syndrome	0.00134	0.0101	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.00134	0.0101	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCR9—epilepsy syndrome	0.00134	0.0101	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PPIA—epilepsy syndrome	0.00131	0.00988	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GRM3—epilepsy syndrome	0.00131	0.00987	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GRM4—epilepsy syndrome	0.00131	0.00987	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DUSP4—epilepsy syndrome	0.00129	0.00969	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SSTR2—epilepsy syndrome	0.00129	0.00969	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PGF—epilepsy syndrome	0.00124	0.00936	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GRM8—epilepsy syndrome	0.00124	0.00936	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—OPRD1—epilepsy syndrome	0.00119	0.00893	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GNAO1—epilepsy syndrome	0.00119	0.00893	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CHRM1—epilepsy syndrome	0.00114	0.00856	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GRM1—epilepsy syndrome	0.00114	0.00856	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDYN—epilepsy syndrome	0.00114	0.00856	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCR7—epilepsy syndrome	0.00114	0.00856	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GAL—epilepsy syndrome	0.00107	0.00805	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GFAP—epilepsy syndrome	0.00107	0.00805	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CASP2—epilepsy syndrome	0.00106	0.00796	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CHRM3—epilepsy syndrome	0.00106	0.00796	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GRM5—epilepsy syndrome	0.00106	0.00796	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CX3CR1—epilepsy syndrome	0.00101	0.00763	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000995	0.00748	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CHRM2—epilepsy syndrome	0.000995	0.00748	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000995	0.00748	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SLC2A1—epilepsy syndrome	0.000974	0.00732	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GABBR1—epilepsy syndrome	0.000968	0.00728	CbGpPWpGaD
Nitroxoline—METAP2—Disease—JUNB—epilepsy syndrome	0.000967	0.00727	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOS1—epilepsy syndrome	0.00096	0.00722	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HRH3—epilepsy syndrome	0.000928	0.00698	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HBEGF—epilepsy syndrome	0.000915	0.00688	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—OPRM1—epilepsy syndrome	0.000913	0.00687	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT3—epilepsy syndrome	0.000899	0.00676	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ADAM10—epilepsy syndrome	0.000878	0.0066	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCR3—epilepsy syndrome	0.000863	0.00649	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NPY—epilepsy syndrome	0.000841	0.00632	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000841	0.00632	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDC42—epilepsy syndrome	0.00082	0.00616	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCL3—epilepsy syndrome	0.000811	0.0061	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HSPB1—epilepsy syndrome	0.000811	0.0061	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL2—epilepsy syndrome	0.000811	0.0061	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—OXT—epilepsy syndrome	0.000811	0.0061	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CRH—epilepsy syndrome	0.000811	0.0061	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TSC1—epilepsy syndrome	0.000754	0.00567	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTK2B—epilepsy syndrome	0.000754	0.00567	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HES1—epilepsy syndrome	0.000751	0.00564	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NTRK2—epilepsy syndrome	0.000733	0.00551	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCR2—epilepsy syndrome	0.000733	0.00551	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SST—epilepsy syndrome	0.000733	0.00551	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FYN—epilepsy syndrome	0.00073	0.00549	CbGpPWpGaD
Nitroxoline—METAP2—Disease—H2AFX—epilepsy syndrome	0.000727	0.00547	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DUSP6—epilepsy syndrome	0.000727	0.00547	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000718	0.0054	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PLAT—epilepsy syndrome	0.000715	0.00537	CbGpPWpGaD
Nitroxoline—METAP2—Disease—YWHAZ—epilepsy syndrome	0.000702	0.00528	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BDKRB2—epilepsy syndrome	0.00069	0.00518	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL12—epilepsy syndrome	0.00069	0.00518	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JUNB—epilepsy syndrome	0.000677	0.00509	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CNR1—epilepsy syndrome	0.000677	0.00509	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CCR5—epilepsy syndrome	0.000675	0.00507	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PLCB1—epilepsy syndrome	0.000674	0.00507	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HTR7—epilepsy syndrome	0.00066	0.00497	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HBEGF—epilepsy syndrome	0.000641	0.00482	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT3—epilepsy syndrome	0.000629	0.00473	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TSC2—epilepsy syndrome	0.000627	0.00472	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADAM10—epilepsy syndrome	0.000615	0.00462	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APOE—epilepsy syndrome	0.000614	0.00462	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—S100B—epilepsy syndrome	0.000581	0.00437	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6ST—epilepsy syndrome	0.000577	0.00434	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SOCS3—epilepsy syndrome	0.000576	0.00433	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDC42—epilepsy syndrome	0.000574	0.00432	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOS2—epilepsy syndrome	0.000572	0.0043	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AVP—epilepsy syndrome	0.000556	0.00418	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HES1—epilepsy syndrome	0.000526	0.00395	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FYN—epilepsy syndrome	0.000511	0.00384	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—H2AFX—epilepsy syndrome	0.000509	0.00383	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MEF2C—epilepsy syndrome	0.000508	0.00382	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000491	0.00369	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NGF—epilepsy syndrome	0.000486	0.00365	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCR5—epilepsy syndrome	0.000473	0.00355	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF2—epilepsy syndrome	0.000466	0.00351	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HTR2A—epilepsy syndrome	0.000463	0.00348	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TSC2—epilepsy syndrome	0.000439	0.0033	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AGT—epilepsy syndrome	0.000439	0.0033	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APOE—epilepsy syndrome	0.00043	0.00323	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTOR—epilepsy syndrome	0.000425	0.00319	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KDR—epilepsy syndrome	0.000421	0.00317	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTGS2—epilepsy syndrome	0.000421	0.00316	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKCB—epilepsy syndrome	0.000405	0.00305	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6ST—epilepsy syndrome	0.000404	0.00304	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—POMC—epilepsy syndrome	0.000369	0.00278	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCL2—epilepsy syndrome	0.000361	0.00272	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SRC—epilepsy syndrome	0.00034	0.00256	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF2—epilepsy syndrome	0.000327	0.00246	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RELA—epilepsy syndrome	0.000303	0.00228	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MTOR—epilepsy syndrome	0.000297	0.00224	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CASP3—epilepsy syndrome	0.000273	0.00206	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JUN—epilepsy syndrome	0.000266	0.002	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MMP9—epilepsy syndrome	0.000258	0.00194	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SRC—epilepsy syndrome	0.000238	0.00179	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VEGFA—epilepsy syndrome	0.000232	0.00174	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT1—epilepsy syndrome	0.000211	0.00159	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT1—epilepsy syndrome	0.000148	0.00111	CbGpPWpGaD
